The acquisition of BMP Sunstone, which holds many leading Chinese pediatric and hygienic brands, will provide Sanofi-aventis with significant growth opportunities in the Chinese healthcare market, and specifically in its two largest categories: Vitamin & Minerals Supplements and Cough & Cold.
This transaction marks the largest Chinese pharmaceutical deal of the year, and is a prime example of the synergies and value that cross-border transactions can create. E. J. McKay CEO James Z. Li stated, "We are very pleased with the positive outcome. This acquisition will significantly boost Sanofi-aventis' China presence, meanwhile creating significant value for BMP Sunstone's shareholders. It is representative of the selectivity of our clients and the value and expertise E. J. McKay provides."
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Reporting revenue of EUR29.3 billion in 2009, the company maintains over 100,000 employees in over 100 countries.
About BMP Sunstone
BMP Sunstone Corporation is a specialty pharmaceutical company that is
building a proprietary portfolio of branded pharmaceutical and healthcare
products in China. Through Sunstone, the Company manufactures leading
pediatric and women's health products sold in pharmacies throughout the
country. The Company also markets a portfolio of products u
|SOURCE E. J. McKay|
Copyright©2010 PR Newswire.
All rights reserved